You are here

Clinical Trials: Heart Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, June 29, 2023 - 12:00
Condition:   Heart Failure, Systolic
Intervention:   Combination Product: CardiALLO™ Human Allogenic Culture-expanded Bone marrow-derived Mesenchymal Stem Cells (hMSCs)
Sponsor:   BioCardia, Inc.
Not yet recruiting
Posted: Friday, March 17, 2023 - 12:00
Condition:   Heart Failure With Reduced Ejection Fraction
Intervention:   Biological: Extracellular vesicle-enriched secretome of cardiovascular progenitor cells differentiated from induced pluripotent stem cells
Sponsors:   Assistance Publique - Hôpitaux de Paris;   Ministry of Health, France
Not yet recruiting
Posted: Monday, February 13, 2023 - 12:00
Condition:   Safety Issues
Intervention:   Biological: OmniMSC-AMI
Sponsor:   Taiwan Bio Therapeutics Co., Ltd.
Not yet recruiting
Posted: Friday, February 3, 2023 - 12:00
Condition:   Refractory Angina Pectoris
Interventions:   Biological: Bone marrow aspiration and intracoronary infusion of autologous bone marrow-derived cells;   Procedure: Sham bone marrow aspiration and insertion of vascular access sheath
Sponsor:   Barts & The London NHS Trust
Not yet recruiting
Posted: Friday, December 30, 2022 - 12:00
Conditions:   Myocardial Infarction;   Myocardial Ischemia;   Myocardial Stunning
Intervention:   Biological: mitochondria and MSC-derived exosomes
Sponsor:   Tehran University of Medical Sciences
Posted: Wednesday, November 30, 2022 - 12:00
Conditions:   Ischemic Heart Disease;   Ischemic Cardiomyopathy;   Heart Failure, Systolic;   Heart Failure NYHA Class III;   Heart Failure NYHA Class II;   Heart Failure NYHA Class IV;   Coronary Artery Disease
Interventions:   Procedure: Epicardial AAMs-patch transplantation;   Diagnostic Test: RNA-stabilized whole blood sampling;   Diagnostic Test: Plasma sampling;   Diagnostic Test: Transthoracic echocardiography;   Diagnostic Test: Late-gadolinium enhancement cardiac magnetic resonance imaging (LGE-CMRI);   Other: Symptom-scaling;   Other: 6-minute walking test (6MWT);   Diagnostic Test: Blood sampling (NT-proBNP);   Diagnostic Test: Transesophageal echocardiography
Sponsors:   Hospital District of Helsinki and Uusimaa;   University of Helsinki
Not yet recruiting
Posted: Tuesday, November 22, 2022 - 12:00
Conditions:   Myocardial Reperfusion Injury;   Treatment Outcome;   Prognosis;   ST Elevation Myocardial Infarction
Intervention:   Device: Extracorporeal cardiac shock wave therapy(ECSW)
Sponsor:   The First Affiliated Hospital of Kunming Medical College
Not yet recruiting
Posted: Wednesday, October 26, 2022 - 12:00
Condition:   Chronic Obstructive Pulmonary Disease (COPD)
Intervention:   Biological: Autologuos transplantation of bronchial basal cells
Sponsors:   Guangzhou Institute of Respiratory Disease;   Regend Therapeutics
Posted: Friday, June 10, 2022 - 12:00
Conditions:   Heart Disease, Ischemic;   Hyperlipidemias;   Hypertension
Intervention:   Other: Whole-Food, Plant-Based Diet and Low-Carbohydrate Diet
Sponsor:   University of Rochester
Not yet recruiting
Posted: Tuesday, December 7, 2021 - 12:00
Conditions:   Congestive Heart Failure;   Angina
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine